Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0
Price to sales ratio
0.13

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
7472
BIVIW
BioVie Inc. - Warrant
0.5850 USD0.00%+25.81%+95.20%+46.43%11.92 M USD
7473
OABI
OmniAb, Inc. - Common Stock
2.14 USD+1.42%-6.96%-7.36%+3.38%11.73 M USD
7491
MLECW
Moolec Science SA - Warrant
0.0169 USD-0.59%+32.03%+6.96%+14.19%5.43 M USD
7493
CDIOW
Cardio Diagnostics Holdings Inc. - Warrant
0.0152 USD0.00%+0.66%-16.02%+1.33%5.39 M USD

Frequently asked questions about Aspire Biopharma Holdings, Inc. - Warrant

What is the Aspire Biopharma Holdings, Inc. - Warrant stock price today?

The current price of Aspire Biopharma Holdings, Inc. - Warrant (ASBPW) is 0.0239. Over the past 24 hours, the stock has changed by +19.50%. Follow the ASBPW chart for real-time price dynamics.

What is the stock ticker of Aspire Biopharma Holdings, Inc. - Warrant?

Aspire Biopharma Holdings, Inc. - Warrant trades under the ticker ASBPW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Aspire Biopharma Holdings, Inc. - Warrant stock going up?

ASBPW has changed by +19.50% over the last week, +19.50% over the last month, and -56.23% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Aspire Biopharma Holdings, Inc. - Warrant release financial reports?

Yes. You can track Aspire Biopharma Holdings, Inc. - Warrant financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Aspire Biopharma Holdings, Inc. - Warrant net income for the last quarter?

Aspire Biopharma Holdings, Inc. - Warrant reported net income of -3.22 M for the last quarter. The previous quarter showed -4.71 M, which means net income changed by +31.54%.

What is Aspire Biopharma Holdings, Inc. - Warrant EBITDA?

Aspire Biopharma Holdings, Inc. - Warrant EBITDA is -62.28 K, and its EBITDA margin is -219.66%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Aspire Biopharma Holdings, Inc. - Warrant stock?

You can buy Aspire Biopharma Holdings, Inc. - Warrant (ASBPW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Aspire Biopharma Holdings, Inc. - Warrant stock?

Investing in Aspire Biopharma Holdings, Inc. - Warrant requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ASBPW chart and related analysis on metatrader.com as part of your research.